Literature DB >> 33645253

Precision and accuracy of hyperglycemic clamps in a multicenter study.

Kieren J Mather1, Ashley H Tjaden2, Adam Hoehn3, Kristen J Nadeau4, Thomas A Buchanan5, Steven E Kahn6, Silva A Arslanian7, Sonia Caprio8, Karen M Atkinson6, Melanie Cree-Green4, Kristina M Utzschneider6, Sharon L Edelstein2.   

Abstract

Application of glucose clamp methodologies in multicenter studies brings challenges for standardization. The Restoring Insulin Secretion (RISE) Consortium implemented a hyperglycemic clamp protocol across seven centers using a combination of technical and management approaches to achieve standardization. Two-stage hyperglycemic clamps with glucose targets of 200 mg/dL and >450 mg/dL were performed utilizing a centralized spreadsheet-based algorithm that guided dextrose infusion rates using bedside plasma glucose measurements. Clamp operators received initial and repeated training with ongoing feedback based on surveillance of clamp performance. The precision and accuracy of the achieved stage-specific glucose targets were evaluated, including differences by study center. We also evaluated robustness of the method to baseline physiologic differences and on-study treatment effects. The RISE approach produced high overall precision (3%-9% variance in achieved plasma glucose from target at various times across the procedure) and accuracy (SD < 10% overall). Statistically significant but numerically small differences in achieved target glucose concentrations were observed across study centers, within the magnitude of the observed technical variability. Variation of the achieved target glucose over time in placebo-treated individuals was low (<3% variation), and the method was robust to differences in baseline physiology (youth vs. adult, IGT vs. diabetes status) and differences in physiology induced by study treatments. The RISE approach to standardization of the hyperglycemic clamp methodology across multiple study centers produced technically excellent standardization of achieved glucose concentrations. This approach provides a reliable method for implementing glucose clamp methodology across multiple study centers.NEW & NOTEWORTHY The Restoring Insulin Secretion (RISE) study centers undertook hyperglycemic clamps using a simplified methodology and a decision guidance algorithm implemented in an easy-to-use spreadsheet. This approach, combined with active management including ongoing central data surveillance and routine feedback to study centers, produced technically excellent standardization of achieved glucose concentrations on repeat studies within and across study centers.

Entities:  

Keywords:  accuracy; glucose clamp; methodology; multicenter; precision

Mesh:

Substances:

Year:  2021        PMID: 33645253      PMCID: PMC8238133          DOI: 10.1152/ajpendo.00598.2020

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  39 in total

1.  Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes.

Authors:  Melanie Cree-Green; Bryan C Bergman; Eda Cengiz; Larry A Fox; Tamara S Hannon; Kellee Miller; Brandon Nathan; Laura Pyle; Darcy Kahn; Michael Tansey; Eileen Tichy; Eva Tsalikian; Ingrid Libman; Kristen J Nadeau
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

2.  Effects of arterial versus venous sampling on analysis of glucose kinetics in man.

Authors:  E A McGuire; J H Helderman; J D Tobin; R Andres; M Berman
Journal:  J Appl Physiol       Date:  1976-10       Impact factor: 3.531

3.  Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2019-06-09       Impact factor: 19.112

4.  Insulin control of glucose metabolism in man: a new kinetic analysis.

Authors:  P A Insel; J E Liljenquist; J D Tobin; R S Sherwin; P Watkins; R Andres; M Berman
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

5.  The evaluation of the ability of closed-loop glycemic control device to maintain the blood glucose concentration in intensive care unit patients.

Authors:  Tomoaki Yatabe; Rie Yamazaki; Hiroyuki Kitagawa; Takehiro Okabayashi; Koichi Yamashita; Kazuhiro Hanazaki; Masataka Yokoyama
Journal:  Crit Care Med       Date:  2011-03       Impact factor: 7.598

6.  Repeatability and reproducibility of the hyperinsulinemic-euglycemic clamp and the tracer dilution technique in a controlled inpatient setting.

Authors:  Duc Son N T Le; Thomas Brookshire; Jonathan Krakoff; Joy C Bunt
Journal:  Metabolism       Date:  2009-03       Impact factor: 8.694

7.  Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine.

Authors:  H Larsson; B Ahrén
Journal:  Diabetologia       Date:  1998-07       Impact factor: 10.122

8.  Unbiased and flexible iterative computer program to achieve glucose clamping.

Authors:  D R Matthews; J P Hosker
Journal:  Diabetes Care       Date:  1989-02       Impact factor: 19.112

9.  Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study.

Authors:  M Laakso; J Zilinskaite; T Hansen; T Welløv Boesgaard; M Vänttinen; A Stancáková; P-A Jansson; F Pellmé; J J Holst; T Kuulasmaa; M L Hribal; G Sesti; N Stefan; A Fritsche; H Häring; O Pedersen; U Smith
Journal:  Diabetologia       Date:  2007-12-14       Impact factor: 10.122

10.  Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study.

Authors:  Cosimo Giannini; Ram Weiss; Anna Cali; Riccardo Bonadonna; Nicola Santoro; Bridget Pierpont; Melissa Shaw; Sonia Caprio
Journal:  Diabetes       Date:  2012-02-07       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.